21
Advance Topics in Change Management Lecture 11: Organizational Size, Growth and Decline

Advance Topics in Change Management Lecture 11: Organizational Size, Growth and Decline

Embed Size (px)

Citation preview

Page 1: Advance Topics in Change Management Lecture 11: Organizational Size, Growth and Decline

Advance Topics in Change Management

Lecture 11: Organizational Size, Growth and Decline

Page 2: Advance Topics in Change Management Lecture 11: Organizational Size, Growth and Decline

Objectives

• To consider how the size of an organization affects its structure.

• To explore the ‘organizational life cycle’.

• To examine the need for bureaucracy as a means of control in large organizations.

• To explore ways in which organizations can be revitalized.

Page 3: Advance Topics in Change Management Lecture 11: Organizational Size, Growth and Decline

SIZE AND STRUCTURE

• Increasing number of employees leads to:– Increasing formalisation of procedures– Increasing role specialisation– More delegation to senior managers

• And to:– Proportionately fewer top managers but more

professionals– Especially in organizations with between 100 and

2000 employees

Page 4: Advance Topics in Change Management Lecture 11: Organizational Size, Growth and Decline
Page 5: Advance Topics in Change Management Lecture 11: Organizational Size, Growth and Decline

An Example of Moving from Stage 1 to Stage 2 and then to Stage 3

April 2003 Development of wave-energy device begins• Researchers at Queen's University Belfast begin developing Oyster wave

power technology.

February 2005 Aquamarine Power established• Aquamarine Power is established to commercialise Oyster wave power

technology.

October 2007 Aquamarine Power joins forces with SSE• Scottish and Southern Energy, a large UK utility firm, buys a stake in

Aquamarine Power. 

August 2008 Appointment of management team• Aquamarine Power appoints an experienced management team led by CEO

Martin McAdam.

August 2010 Company expands to about 100 employees• Divisional managers (different engineering functions, manufacturing, marketing)

appointed

Page 6: Advance Topics in Change Management Lecture 11: Organizational Size, Growth and Decline

CHARACTERISTICS OF DEVELOPMENT STAGES I

I II III IV

ENTREPRENEUR’L COLLECTIVITY FORMALIZATION ELABORATION

CHARACTERISTIC NON-BUREAUCRATIC

PRE-BUREAUCRATIC

BUREAUCRATIC DECENTRALIZED BUREAUCRATIC

STRUCTURE INFORMAL, ONE-PERSON SHOW

MOSTLY INFORMAL SOME PROCEDURES

FORMAL PROCEDURES DIVISION OF LABOUR ADD NEW SPECIALITIES

TEAM-WORK WITHIN BUREAUCRACY, SMALL COMPANY THINKING

PRODUCT/SERVICE

SINGLE PRODUCT/ SERVICES

MAJOR PRODUCT/ SERVICES

LINE OF PRODUCT/ SERVICES

MULTIPLE LINES

REWARD AND CONTROL SYSTEMS

PERSONAL, PATERNALISTIC

PERSONAL, CONTRIBUTION TO SUCCESS

IMPERSONAL, FORMALISED SYSTEMS

EXTENSIVE, TAILORED TO PRODUCT AND DEPARTMENT

Page 7: Advance Topics in Change Management Lecture 11: Organizational Size, Growth and Decline

CHARACTERISTICS OF DEVELOPMENT STAGES II

I II III IV

ENTREPRENEUR’L COLLECTIVITY FORMALIZATION ELABORATION

CHARACTERISTIC NON-BUREAUCRATIC

PRE-BUREAUCRATIC

BUREAUCRATIC DECENTRALIZED BUREAUCRATIC

INNOVATION BY OWNER / MANAGER

BY EMPLOYEES AND MANAGERS

BY SEPARATE INNOVATION GROUP

BY INSTITUTIONAL’D R&D DEPT

GOAL SURVIVAL GROWTH INTERNAL STABILITY, EXPAND MARKET

ENHANCE REPUTATION

TOP MANAGEMENT STYLE

INDIVIDUALISTIC, ENTREPRENEUR’L

CHARISMATIC, GIVES DIRECTION

DELEGATION WITH CONTROL

PARTICIPATION TEAM APPROACH

Page 8: Advance Topics in Change Management Lecture 11: Organizational Size, Growth and Decline

GlaxoSmithKline - Questions

• Read the FT article on GSK.

• Where would you place it on the organizational life cycle and why?

• How would you describe GSK’s reward and control systems?

• What ‘routines’ can you identify in the article?

• How are these related to its objectives?

Page 9: Advance Topics in Change Management Lecture 11: Organizational Size, Growth and Decline

GSK• Moving into elaboration (decentralized teamwork)

phase• The unit, a semi-autonomous business with an

entrepreneurial culture more typical of a small biotechnology company than a drug multinational, became their reference point for the creation in early 2001 of seven "centres of excellence for drug discovery" (CEDDs) in Europe and the US, of which Stevenage houses two.

• The heart of his strategy was the creation of "fully empowered, multi-disciplinary teams" of no more than 300 people - the size of many of the successful biotech companies with which GSK and its rivals have signed alliances. "I only rigidly control the headcount," he says. "300 is a human size where people can hold each other accountable."

Page 10: Advance Topics in Change Management Lecture 11: Organizational Size, Growth and Decline

GSK Moving into elaboration phase• However, CEDDs have made a big difference. The

first has been the ability to stop and start research projects more quickly than in the past, saving substantial research costs. "Before, we could be stuck for years with a project that was not viable, because the visibility was not there. The layers of management between me, the leadership team and the bench scientists have been compressed." A second change has been tighter integration of chemistry and biology, creating an approach dubbed "medicinal chemistry".

• In the same way, the CEDD co-operates closely with other parts of GSK. That has led to early co-operation as specialists from both sites discuss how far ideas developed in the laboratory are practicable for large-scale manufacture.

• each CEDD has its own finance director

Page 11: Advance Topics in Change Management Lecture 11: Organizational Size, Growth and Decline

GSK – Pay

• Extensive – presumably; tailored – hard to say:

• A final factor with the CEDDs is performance-linked remuneration, which accounts for about 20 per cent of the scientists' pay. But, as in any company, Mr Rapeport concedes that devising individual targets for team members is difficult.

• Social control

Page 12: Advance Topics in Change Management Lecture 11: Organizational Size, Growth and Decline

GSK – Routines

• Multidisciplinary teams – finance, manufacturing, chemists, biologists

• "nodes" on each floor where staff sit and are encouraged to sip free coffee while exchanging ideas. – Underpins idea that collaboration and

teamwork are important

• All to increase the speed of drug development

Page 13: Advance Topics in Change Management Lecture 11: Organizational Size, Growth and Decline

FIVE PHASES OF ORGANISATIONAL DEVELOPMENT I

1 2 3

BIRTH GROWTH MATURITY

FREQUENT INNOVATION BROADEN PRODUCT LINES FEW CHANGES

FINDING UNFILLED NICHES

INCREMENTAL INNOVATION

FOLLOW COMPETITION

USE OF MIDDLEMEN MARKET SEGMENTATION BROADER MARKETS

VERTICAL INTEGRATION LOBBYING LARGE

SMALL RELATED ACQUISITIONS ENLARGED OWNERSHIP

ONE, OR FEW, OWNERS INCREASED SIZE DIVERSE BOARD

SIMPLE, CENTRALISED BROADER OWNERSHIP FUNCTIONAL

RISK TAKING FUNCTIONAL SALARIED MANAGERS

INCREASED STAFF LESS DELEGATION

LESS RISK TAKING EFFICIENCY FOCUS

CONSERVATIVE DECISIONS

Page 14: Advance Topics in Change Management Lecture 11: Organizational Size, Growth and Decline

FIVE PHASES OF ORGANISATIONAL DEVELOPMENT II

4 5

REVIVAL DECLINE

MANY INNOVATIONS PRICE CUTS

DIVERSIFICATION OUTDATED PRODUCTS

NEW MARKETS SHRINKING MARKETS

MANY OWNERS NO CLEAR STRATEGY

DIVISIONAL RESTRICTED OWNERSHIP

CENTRALISED STRATEGY SIMPLE STRUCTURE

DECENTRALISED OPS. CENTRALISED

INCREASED SCANNING LITTLE SCANNING

RISK TAKING EXTREME CONSERVATISM

LITTLE INNOVATION

RISK AVERSE

Page 15: Advance Topics in Change Management Lecture 11: Organizational Size, Growth and Decline

Phases of Organisational Decline: Problems and Remedies

Problem phases Remedies

Blinded Good information

Inaction Diagnose and implement change

Faulty Action Correct mistakes and maintain commitment

Crisis Effective re-organisation

Dissolution None

Page 16: Advance Topics in Change Management Lecture 11: Organizational Size, Growth and Decline

Corporate Turnaround:Phases in Revitalisation

• Facing the crisis: retrenchment and cost cutting: reactive phase

• Reinvestment: focusing on core skills and investing in them for the future

• Rebuilding: reshaping the organisation around the new goals and skills for the future

Page 17: Advance Topics in Change Management Lecture 11: Organizational Size, Growth and Decline

Leadership in CorporateTurnaround Situations

• New Visions

• Mobilising Commitment

• Changing routines and structures to support the new strategy

Page 18: Advance Topics in Change Management Lecture 11: Organizational Size, Growth and Decline

Corporate Turnarounds: Fiat - Marchionne’s gamble and One Way

to Mobilise Commitment!• The reason for the unions’ anger was Mr Marchionne’s

[CEO of Fiat and Chrysler] great gamble. In a last-ditch attempt to fix Fiat’s loss-making Italian manufacturing base, he is promising to invest €20bn ($27bn) to double the country’s vehicle production by 2014.

• But it comes at a price: in return, Italian workers, who are among the world’s most protected, must adopt US-style flexible contracts. If they refuse, Mr Marchionne will pull Italy’s biggest private employer out of the country altogether. Industrial jobs seen as a birthright in Fiat’s home market could go to lower-cost sites in Poland, Serbia – where Fiat owns the vast former Zastava plant that once made the cheap Yugo car – or elsewhere.

• http://www.ft.com/cms/s/0/a9e53516-cbf5-11df-bd28-00144feab49a.html 30 September 2010

Page 19: Advance Topics in Change Management Lecture 11: Organizational Size, Growth and Decline

Other Ways to Prevent Corporate Decline

• Acquire emerging companies– But potentially risky

• Diversify into unrelated areas

• Radically alter the focus of the company

• Establish joint ventures/strategic alliances to learn!

Page 20: Advance Topics in Change Management Lecture 11: Organizational Size, Growth and Decline

REQUIREMENTS FOR LEARNING FROM JOINT VENTURES AND ALLIANCES

• Recognition of the value of joint venture as a mechanism of learning

• Willingness to collaborate openly, whilst being aware of ‘no-go’ areas

• Making learning an explicit goal• Focus on long-term learning, not short-term

outputs• Capacity to learn

– Transferability of the knowledge– Receptivity of employees to learning– Absorptive capacity of the firm– Previous experience in learning

Page 21: Advance Topics in Change Management Lecture 11: Organizational Size, Growth and Decline

Conclusions

• There are general patterns to the ways in which organizational structures change as firms grow.

• These are not, however, set in stone.• There are several ways in which

companies can try to fight off decline and dissolution.

• These may be easier to achieve in theory than in practice.